Company Filing History:
Years Active: 1999-2008
Title: The Innovations of Shozo Shoji
Introduction
Shozo Shoji is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of cyclic peptides and AIDS vaccines. His work has the potential to impact the treatment and prevention of HIV infections.
Latest Patents
Shozo Shoji holds 3 patents related to his innovative research. His latest patents focus on cyclic peptides that comprise specific amino acid sequences, which are designed to neutralize the second receptors utilized by the HIV-1 virus during human infection. These cyclic peptides are not only crucial for understanding the mechanisms of HIV infection but also serve as active ingredients in AIDS vaccines. The patents detail the importance of binding substituent groups to active groups within the cyclic peptides to enhance in vivo absorption and antibody formation.
Career Highlights
Shoji is currently associated with Nissui Pharmaceutical Co., Ltd., where he continues to advance his research in the field of pharmaceuticals. His work has garnered attention for its innovative approach to combating viral infections, particularly HIV.
Collaborations
Shozo Shoji collaborates with Kuniomi Tachibana, contributing to the development of groundbreaking solutions in the pharmaceutical industry.
Conclusion
Shozo Shoji's contributions to cyclic peptides and AIDS vaccines highlight his role as a key innovator in biotechnology. His work not only advances scientific understanding but also offers hope for effective treatments against HIV.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.